Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | S100B | P04271 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.36 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | PGK1 | P00558 | 2/20 | 0.34 |
| ▸ | NQO2 | P16083 | 1/20 | 0.34 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29600727 | 1.00 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL22401705 | 0.85 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL449675 | 0.80 | HDAC6 (0.37) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL30690930 | 0.80 | HDAC6 (0.37) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL21523292 | 0.79 | HDAC6 (0.39) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL29751992 | 0.76 | HDAC6 (0.44) | ALDH1A1KDM4EMAPTMAPK1HDAC6 | |
| SCHEMBL9700631 | 0.75 | NQO2 (0.52) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL10808616 | 0.75 | KDM4E (0.41) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL10808625 | 0.75 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD | |
| SCHEMBL10479158 | 0.73 | MAPT (0.52) | ALDH1A1SMN1; SMN2KDM4EGLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2601048-A2 | COMPOSITIONS AND METHODS FOR DETECTION OF SOILS ON FABRICS | The Sun Products Corporation (US) | 2013-06-12 | — | — | EP | disclosed |
| US-20120196375-A1 | Compositions and Methods for Detection of Soils on Fabrics | THE SUN PRODUCTS CORPORATION (US) | 2012-08-02 | — | — | US | disclosed |
| WO-2012019030-A2 | COMPOSITIONS AND METHODS FOR DETECTION OF SOILS ON FABRICS | THE SUN PRODUCTS CORPORATION (US) | 2012-02-09 | — | — | WO | disclosed |
| US-7981686-B2 | Indicator for assessing body odor, process for producing the same, body odor assessment method, method of assessing efficaciousness of deodorant and kit for conveniently assessing body odor | KAO CORPORATION (JP) | 2011-07-19 | — | — | US | disclosed |
| US-20100184122-A1 | INDICATOR FOR ASSESSING BODY ODOR, PROCESS FOR PRODUCING THE SAME, BODY ODOR ASSESSMENT METHOD, METHOD OF ASSESSING EFFICACIOUSNESS OF DEODORANT AND KIT FOR CONVENIENTLY ASSESSING BODY ODOR | KAO CORPORATION (JP) | 2010-07-22 | — | — | US | disclosed |
| US-20060160240-A1 | Indicator for assessing body odor, process for producing the same, body odor assessment method, method of assessing efficaciousness of deodorant and kit for conveniently assessing body odor | KAO CORPORATION (JP) | 2006-07-20 | — | — | US | disclosed |
| EP-1553411-A1 | INDICATOR FOR ASSESSING BODY ODOR, PROCESS FOR PRODUCING THE SAME, BODY ODOR ASSESSMENT METHOD, METHOD OF ASSESSING EFFICACIOUSNESS OF DEODORANT AND KIT FOR CONVENIENTLY ASSESING BODY ODOR | Kao Corporation (JP) | 2005-07-13 | — | — | EP | disclosed |
| EP-1181283-B1 | DIAMINOTHIAZOLES AND THEIR USE FOR INHIBITING PROTEIN KINASES | AGOURON PHARMA (US) | 2005-02-02 | — | — | EP | disclosed |
| US-6620828-B2 | Antiproliferative agents | AGOURON PHARMACEUTICALS, INC. | 2003-09-16 | — | — | US | disclosed |
| US-20020025976-A1 | Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use | AGOURON PHARMACEUTICALS, INC. | 2002-02-28 | — | — | US | disclosed |
| US-5790627-A | Method and apparatus for observing a specimen using an X-ray microscope | RESEARCH DEVELOPMENT CORP. (JP) | 1998-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020025976-A1 | Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use | BRAF, CDK2, CHUK | ALDH1A1 2580/4885SMN1; SMN2 4704/4885KDM4E 2918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.